B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors
B7-H3 可用于预测接受 EGFR 酪氨酸激酶抑制剂治疗的肺腺癌患者的临床结果
期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-022-02634-x
Ying Yang, Jun-Feng Huang, Bing-Qi Hu, Jing Zhou, Xian Wang, Zhen-Zhong Feng, Yu-Ting Chen, Fa-Ming Pan, Huai-Dong Cheng, Li-Wen Chen